대한유방검진의학회

의료소식

home > 유방검진에 대해 > 의료소식
국민건강!유방암조기발견
유방촬영술, 미국 정부 제안처럼 50대로 바꿔야 할까? (RSNA Weekly 09-11-17) By 관리자 / 2009-11-25 PM 03:49 / 조회 : 6667회
논란이 되고 있는 USPSTF Raises Recommended Mammography Screening Age to 50 원문을 읽어보자.


USPSTF Raises Recommended Mammography Screening Age to 50


The United States Preventive Services Task Force (USPSTF) has changed its recommendation on mammography screening, advising women to start at age 50 rather than 40. Since 2002, USPSTF had recommended screening mammography every one to two years for women ages 40 and older. The group's new guidelines, which are different from those of some professional and advocacy organizations, are published online in The Annals of Internal Medicine.

They are likely to touch off more discussion over the benefits of screening for breast cancer. The National Cancer Institute says that it is re-evaluating its guidelines in light of the task force's report. However, the American Cancer Society and the American College of Radiology both say they are staying with their guidelines advising annual mammograms starting at age 40.

The cancer society, in a statement by Dr. Otis Brawley, its chief medical officer, agrees that mammography had risks as well as benefits but, he says, the society's experts have looked at "virtually all" the task force and additional data and concluded that the benefits of annual mammograms starting at age 40 outweigh the risks. Other advocacy groups, like the National Breast Cancer Coalition, Breast Cancer Action, and the National Women's Health Network, welcome the new guidelines. Researchers based the new recommendations on analysis of the efficacy of five breast screening modalities in reducing breast cancer mortality: film mammography; clinical breast examination; breast self-examination; digital mammography; and breast MRI.

In announcing the change, USPSTF acknowledged that "there is convincing evidence that screening with film mammography reduces breast cancer mortality," but that the evidence is strongest for women ages 50 to 74 than for women ages 40 to 49. The strongest evidence is for women ages 60 to 69. The agency found no evidence of a benefit to screening for women older than 75 and no evidence to support clinical breast examination beyond mammography. The new recommendations do not apply to a small group of women with unusual risk factors for breast cancer.


From "In Reversal, Panel Urges Mammograms at 50, Not 40"

New York Times (11/17/09) P. A1; Kolata, Gina